» Articles » PMID: 40000671

Transcriptomic Insights into Early Mechanisms Underlying Post-chikungunya Chronic Inflammatory Joint Disease

Abstract

Chikungunya virus (CHIKV) infection often results in a chronic joint condition known as Post-Chikungunya Chronic Inflammatory Joint Disease (pCHIKV-CIJD). This condition disrupts individuals' daily lives and contributes to increased healthcare expenditure. This study investigated the molecular mechanisms underlying pCHIKV-CIJD development by analyzing RNA transcripts, including small RNAs, of whole blood from CHIKV-infected patients. By comparing patients who evolved to pCHIKV-CIJD with those who did not, we identified molecular signatures associated with chronification in acute and post-acute disease phases. These molecules were primarily associated with an altered immune response regulation. Notably, LIFR, an immune receptor that enhanced IL-6 transcription, was down-regulated in the acute phase of pCHIKV-CIJD patients, while its inhibitor, hsa-miR-98-5p, was up-regulated in these individuals. Other downregulated genes include members of immune mechanisms whose impairment can lead to a reduction in the first line of antiviral response, thereby promoting virus persistence for a longer period in these patients. Additionally, pCHIKV-CIJD patients exhibited reduced transcript levels of MMP8, LFT, and DDIT4, genes already implicated in the pathological process of other types of inflammatory arthritis and seemingly relevant for pCHIKV-CIJD development. Overall, our findings provide insights into the early molecular mechanisms involved in the chronification and highlight potential targets for further investigation.

References
1.
Weaver S, Lecuit M . Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med. 2015; 372(13):1231-9. DOI: 10.1056/NEJMra1406035. View

2.
Bartholomeeusen K, Daniel M, LaBeaud D, Gasque P, Peeling R, Stephenson K . Chikungunya fever. Nat Rev Dis Primers. 2023; 9(1):17. PMC: 11126297. DOI: 10.1038/s41572-023-00429-2. View

3.
Dos Santos Lazari C, Ramundo M, Ten-Caten F, Bressan C, de Filippis A, Manuli E . Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort. PLoS Negl Trop Dis. 2023; 17(1):e0011037. PMC: 9851532. DOI: 10.1371/journal.pntd.0011037. View

4.
Wilson J, Prow N, Schroder W, Ellis J, Cumming H, Gearing L . RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation. PLoS Pathog. 2017; 13(2):e1006155. PMC: 5312928. DOI: 10.1371/journal.ppat.1006155. View

5.
Michlmayr D, Pak T, Rahman A, Amir E, Kim E, Kim-Schulze S . Comprehensive innate immune profiling of chikungunya virus infection in pediatric cases. Mol Syst Biol. 2018; 14(8):e7862. PMC: 6110311. DOI: 10.15252/msb.20177862. View